The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Txagorrapid: Ultrarapid infusion in 30 minutes of the biosimilar of rituximab truxima—A cohort study.
 
Ernesto Perez Persona
Stock and Other Ownership Interests - BioNTech; Moderna Therapeutics; Novavax
Consulting or Advisory Role - Amgen; Celgene; Sanofi
Speakers' Bureau - Abbvie; Amgen; AstraZeneca Spain; Celgene; Incyte; Kern Pharma; Sanofi; Takeda
Travel, Accommodations, Expenses - Abbvie; Janssen; Novartis
 
Laida Cuevas Palomares
No Relationships to Disclose
 
Ariane Unamunzaga Cilaurren
Travel, Accommodations, Expenses - Takeda
 
Xabier Gutierrez López de Gutierrez
Speakers' Bureau - Abbvie; Amgen; Gilead Sciences; Janssen; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Abbvie; Amgen; Gilead Sciences; Janssen; Jazz Pharmaceuticals
 
Buenaventura Buendía Ureña
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Carmen Luisa Molinillo Fernández
No Relationships to Disclose
 
Begoña Benito Ibarrondo
No Relationships to Disclose
 
Ana Isabel Cordero Osua
No Relationships to Disclose
 
Beatriz Benítez Delgado
Travel, Accommodations, Expenses - Takeda
 
Miguel Angel Andrés Moralejo
No Relationships to Disclose
 
Juan José García Albás
No Relationships to Disclose
 
José María Guinea de Castro
Speakers' Bureau - Abbvie; Alexion Pharmaceuticals; AstraZeneca Spain; Kern Pharma; Novartis/Pfizer; SOBI